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Inflammasome assembly activates caspase-1 and
initiates the inflammatory cell death program pyrop-
tosis, which is protective against numerous patho-
gens. Consequently, several pathogens, including
the plague causing bacterium Yersinia pestis, avoid
activating this pathway to enhance their virulence.
However, bacterial molecules that directly modulate
the inflammasome have yet to be identified. Exam-
ining the contribution of Yersinia type III secretion
effectors to caspase-1 activation, we identified the
leucine-rich repeat effector YopM as a potent antag-
onist of both caspase-1 activity and activation. YopM
directly binds caspase-1, which both inhibits
caspase-1 activity and sequesters it to block forma-
tion of the mature inflammasome. Caspase-1 activa-
tion antagonizes Yersinia survival in vivo, and conse-
quently YopM inhibition of caspase-1 is required for
Yersinia pathogenesis. Thus, a bacterium obstructs
pyroptosis utilizing a direct mechanism of caspase-1
inhibition that is distinct from known viral or host
inhibitors.
INTRODUCTION
Pyroptosis is an inherently inflammatory program of cell death
directed by the cysteine protease caspase-1. Activation of cas-
pase-1 is protective against numerous pathogens, but aberrant
activation or dysregulation is harmful to the host and involved
in several inflammatory disorders (Bergsbaken et al., 2009).
Correspondingly, this system is controlled by the nucleotide-
binding domain, leucine-rich repeat-containing (NLR) family of
proteins that detect pathogen-associated molecular patterns
(PAMPs) and initiate a response to an invading pathogen by acti-
vating caspase-1. The resulting cytokine release and cell lysis
creates an inflammatory environment directing immune
responses to the site of infection. Accordingly, several patho-
gens antagonize this pathway to enhance their virulence (Ashida
et al., 2011).
The etiologic agent of plague, Yersinia pestis, and the closely
related pathogen Y. pseudotuberculosis (Ypstb) initially replicateCell Host &in the host without inducing inflammation (Bergsbaken and
Cookson, 2007; Lathem et al., 2005; Price et al., 2012). Yersinia
promote their survival by both evading detection and actively
subverting immune signaling. Yersinia target several cell
signaling pathways, through multiple type III secretion (T3S)
system translocated effector proteins: YopO, YopE, YopM,
YopH, and YopJ (Trosky et al., 2008). One consequence of
T3S by pathogenic bacteria is the cytosolic delivery of microbial
factors that act as PAMPs for the activation of caspase-1 (Lam-
kanfi and Dixit, 2009). While Yersinia can activate caspase-1, the
specific factors detected as PAMPs have not yet been identified
(Bergsbaken and Cookson, 2007; Brodsky et al., 2010).
One factor altering caspase-1 activation during Yersinia infec-
tion is YopK. This T3S regulator restricts effector translocation
into host cells, likely limiting PAMP translocation, and conse-
quently limiting caspase-1 activation as well (Brodsky et al.,
2010; Dewoody et al., 2011). We examined Yersinia effectors
individually for repression of caspase-1 activation and identified
YopM as a potent antagonist of both caspase-1 activity and
activation. We demonstrate that activation of caspase-1 is detri-
mental to Yersinia survival in the host; cell death and inflamma-
tion limit bacterial replication in vivo and promote host survival.
Consequently, YopM inhibition of caspase-1 is a requirement
of Yersinia pathogenesis. YopM acts by directly binding
caspase-1 to block caspase-1 activity, and this binding also
sequesters caspase-1 and aborts inflammasome formation.
The resulting ‘‘preinflammasome’’ contains NLR and the adaptor
protein ASC, but not caspase-1, and appears to be an interme-
diate step of normal inflammasome development. Together,
these data indicate that repression of inflammation by YopM is
important for potentiating the virulence of the deadly pathogen
Yersinia pestis.RESULTS
YopM Prevents Macrophage Pyroptosis in Response
to Yersinia Infection
During infection with Ypstb or Y. pestis, caspase-1 activation
occurs predominantly in activated cells, and either TLR2 or
TLR4 stimuli are sufficient signals for this priming (Bergsbaken
and Cookson, 2007). We observe that caspase-1 activation is
accelerated in macrophages infected with YersiniaD (Figure 1A
and Figure S1 available online), a Ypstb mutant competent for
type III secretion but lacking effector proteins. We thereforeMicrobe 12, 799–805, December 13, 2012 ª2012 Elsevier Inc. 799
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Figure 1. YopM Prevents Caspase-1 Induc-
tion of Pyroptosis
(A–E) Macrophages were infected with the Ypstb
strains indicated. Cells with active caspase-1 were
counted at the times indicated (A) or after 90min of
infection (B and C). Caspase-1 immunoblot of
infected cells indicates that YopM prevents
caspase-1 maturation (D). ELISA shows release
of IL-1b, confirmed by western blot for mature
IL-1b, during YersiniaD infection but not during
infection with YersiniaD expressing YopM in trans
(+pYopM) (E).
(F) Lysosomal exocytosis, determined by immu-
nofluorescence staining of surface LAMP1 on
intact cells, was induced by infection and blocked
by YopM.
(G) Cellular lysis wasmeasured frommacrophages
infected 2 hr with Ypstb; lysis was caspase-1-
dependent (indicating pyroptosis) and blocked by
YopM.
ns, p > 0.05; nd, none detectable. Data in (A–C)
and (E–G) are presented as mean ± SEM. See also
Figure S1.
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Inflammasome Inhibition by Yersiniahypothesized that one or more effector blocks caspase-1 activa-
tion. YopJ induces death by caspase-1-independent apoptosis
(Bergsbaken and Cookson, 2007), and a YopJ allele unique to
Y. pestis KIM activates caspase-1 (Lilo et al., 2008); however,
YopJ deletion in Ypstb did not impact caspase-1 activation (Fig-
ure 1B). The effectors YopO, YopE, and YopH also did not alter
caspase-1 activation (Figure 1B). YopK mutant bacteria acti-
vated greater caspase-1 (Figure 1B), likely due to its regulatory
role in effector translocation (Brodsky et al., 2010; Dewoody
et al., 2011). Significantly enhanced caspase-1 activation also
occurred upon deletion of YopM (Figures 1B and S1), a protein
of enigmatic function, but nonetheless linkedwith anti-inflamma-
tory activity (Leung et al., 1990; McCoy et al., 2010; McDonald
et al., 2003). Complementation with YopM from Ypstb YPIII or
Y. pestis CO92 (99.5% amino acid identity) depressed cas-
pase-1 activation by YersiniaD (Figure 1C). Thus, YopM can
act independently of other effectors and has conserved function
between species, suggesting that YopM is important for both
pathogens.
Caspase-1 activation is typically accompanied by processing
of caspase-1 into p20 and p10 subunits, which is inhibited by
YopM (Figure 1D). Active caspase-1 is required for activation
of the proinflammatory cytokine IL-1b (Bergsbaken et al.,
2009), and release of bioactive IL-1b is also prevented by
YopM (Figure 1E). Additionally, lysosomal exocytosis, a
caspase-1-dependent release of antimicrobial factors that can
act on extracellular bacteria (Bergsbaken et al., 2011) is blocked
by YopM (Figure 1F). The terminal cellular event directed by cas-
pase-1 is lysis, in which the release of inflammatory cellular
contents amplifies local inflammatory responses (Bergsbaken
et al., 2009; Lamkanfi et al., 2010) and deprives intracellular path-
ogens a replicative niche (Miao et al., 2010). YersiniaD induces
lysis, prevented by YopM (Figure 1G). Infection with YersiniaD
does not induce lysis of macrophages from casp1/ mice
(which are also casp11/, an upstream activator of caspase-1
in some circumstances [Kayagaki et al., 2011]) (Figure 1G).
Together, these data indicate that YopM, delivered during800 Cell Host & Microbe 12, 799–805, December 13, 2012 ª2012 ElsYersinia infection into relevant host target cells (Marketon
et al., 2005), blocks important antimicrobial responses directed
by caspase-1.
YopM Promotes Virulence by Inhibiting Caspase-1
In Vivo
Timely inflammation is important in the host’s response to infec-
tion, suggesting that the ability of Yersinia to inhibit caspase-1
could impact bacterial virulence in vivo. YopM mutants are
highly attenuated (Leung et al., 1990; McCoy et al., 2010;
McPhee et al., 2010; Ye et al., 2009), and our in vitro observa-
tions (Figure 1) suggested attenuation may result from the
inability to inhibit caspase-1. Two orders of magnitude more
Ypstb were recovered from wild-type mice when the bacteria
expressed YopM (Figure 2A), highlighting the requirement of
YopM during infection. In caspase-1/ mice, growth of DyopM
Ypstb was restored and comparable to WT Ypstb (Figure 2A),
indicating a major function of YopM in vivo is preventing
caspase-1 activation. Wild-type and caspase-1/ mice are
both susceptible to WT (YopM+) Ypstb (Figure 2B). Wild-type
(caspase-1+/+) mice survive infection with DyopM Ypstb, but
there is attenuation reversal of DyopM Ypstb in caspase-1/
mice (Figure 2C). These results demonstrate that Ypstb is
sensitive to the potent antimicrobial responses directed by
caspase-1; thus, YopM inhibition of caspase-1 in vivo is
required for virulence.
YopM Binds Caspase-1 to Inhibit Activity
Caspase-1 is activated in the inflammasome, a macromolecular
complex formed by NLR family proteins in response to PAMP
stimuli (Bauernfeind et al., 2009; Martinon et al., 2002). The
NLR protein NLRC4 detects bacterial flagellin; NLRP3 activates
caspase-1 in response to numerous stimuli including inorganic
irritants, pore-forming toxins, and nigericin; and NLRP1
responds to Bacillus anthracis lethal toxin (LT). Transduced
YopM protects macrophages from caspase-1 activation in
response to all of these stimuli (Figure 3A), indicating thatevier Inc.
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(A) Four days after intraperitoneal inoculation with
1,000 CFU Ypstb, few bacteria were recovered
from the spleens of C57BL/6 infected with DyopM
Ypstb, while this strain colonized casp1/ mice
similar to fully virulent Ypstb; each point represents
a single mouse.
(B) WT Ypstb is lethal to both wild-type C57BL/6
mice (black) and casp1/ mice (gray).
(C) However, only casp1/ mice are susceptible
to DyopM Ypstb.
Results are from combined experiments. Asterisks
indicate statistical differences by nonparametric
Mann-Whitney U test (titers, A) or Wilcoxon test
(survival curves, B and C). *p < 0.05, **p < 0.005.
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Inflammasome Inhibition by YersiniaYopM is sufficient to block caspase-1 activation triggered by
multiple NLRs and diverse cognate PAMPs.
Avoiding caspase-1 activation is a beneficial strategy for many
pathogenic bacteria (Bergsbaken et al., 2009; Miao et al., 2010),
although bacterial inhibitors specifically antagonizing caspase-1
have yet to be described. For viruses, which similarly benefit
from avoiding or delaying inflammatory responses, several
proteins structurally resembling endogenous host regulators
block caspase-1 activity (Lamkanfi and Dixit, 2009; Nathaniel
et al., 2004). We identified a 4 amino acid sequence in an
exposed loop of YopM similar to caspase-1 substrate YVAD
and to endogenous and virus-encoded inhibitors of caspase-1
(Figure 3B). Immature and active caspase-1 both bind
substrates with equal affinity (Elliott et al., 2009); pseudosub-
strate inhibitors can block either the activation or activity of
caspase-1 (Li et al., 2008), suggesting that YopM may similarly
bind and inactivate caspase-1 (Figure 3C).
Use of recombinant YopM as bait to pull down proteins from
lysates of YersiniaD-infected macrophages undergoing pyropto-
sis confirms that YopM binds endogenous caspase-1 (Fig-
ure 3D). Caspase-1 substrates and pseudosubstrate inhibitors
contain an aspartic acid residue critical for the protein:protein
interaction (Li et al., 2008; Thornberry et al., 1997); alteration of
this amino acid of YopM (Figure 3B) renders the protein
(YopM271A) incapable of binding caspase-1 (Figure 3D). Since
YopM preferentially binds cleaved, active caspase-1 (Figure 3D),
we determined whether substrate hydrolysis by caspase-1 is
blocked by YopM binding. YopM, but not YopM271A, directly
blocks substrate cleavage by purified active caspase-1 (Fig-
ure 3E) without being cleaved itself (Figure S2), indicating that
YopM and caspase-1 directly interact, that YopM occupies the
substrate site of caspase-1, and that a pseudosubstrate
sequence of YopM is required for binding caspase-1.
YopM Blocks Formation of Mature Inflammasomes
During pyroptosis, NLRs complex with the adaptor ASC to form
a structure where procaspase-1 is cleaved into an active state
(Bauernfeind et al., 2009; Martinon et al., 2002; Stehlik et al.,
2003). In vivo, these inflammasome structures are visualized as
a macromolecular complex containing active caspase-1 (Fink
et al., 2008). We hypothesized that YopM binding of caspase-1
might alter the formation or content of natural inflammasomes
formed in response to infection. Ypstb induces formation ofCell Host &NLRP3 foci, a process unaltered by YopM (Figures 4A and 4B).
NLRP3 requires the adaptor protein ASC to bind and activate
caspase-1; formation of ASC-containing pyroptosomes (Fer-
nandes-Alnemri et al., 2007) was similarly unaltered by YopM
(Figures 4C and 4D). Despite assembly of this NLR-ASC ‘‘prein-
flammasome’’ scaffold during infection (Figure S3A), caspase-1
is not recruited into foci in the presence of YopM delivered by
Ypstb (Figures 4E and 4F). Caspase-1 was recruited to the in-
flammasome in the presence of YopM271A, the mutant that
cannot bind caspase-1 (Figure 4F). Further, caspase-1 activation
was blocked in cells in which it could not be recruited to form in-
flammasomes (Figures 4G and 4H), and caspase-1 colocalized
with YopM (Figures 4I and S3B). Consistent with these observa-
tions, YopM, but not YopM271A, blocks caspase-1 activation in
response to PAMPs that activate NLRP1, NLRP3, or NLRC4
inflammasomes (Figure S3C). Together, these results indicate
that naturally delivered YopM preempts caspase-1 activation
by binding and sequestering caspase-1, resulting in the forma-
tion of developmentally arrested preinflammasomes lacking
caspase-1 (Figures 4G and 4H). Thus, YopM blocks pyroptosis
by a unique bifunctional mechanism: the penultimate step of in-
flammasome formation is interrupted and substrate processing
is directly inhibited.
DISCUSSION
Timely induction of inflammation is important for immunity to
many pathogens. Inflammation during Yersinia infection is
biphasic; an initial noninflammatory phase of bacterial replica-
tion is followed by inflammation (Bergsbaken and Cookson,
2007; Lathem et al., 2005; Price et al., 2012). We have demon-
strated that Ypstb not only evades innate immune detection,
as previously presumed, but also more specifically targets
immune cells with an effector to bind and disable caspase-1.
These results provide insight into the exceptional ability of Yersi-
nia to initially replicate in the host without eliciting inflammation.
Our results explain a virulence requirement for YopM that has
previously been enigmatic. Yersinia primarily target macro-
phages for T3S translocation during infection (Marketon et al.,
2005). Using relevant host-derived cells and physiologic quanti-
ties of T3S-delivered YopM, we have identified a critical target of
YopM. Several reports have shown that DyopM Yersinia are hy-
perinflammatory and attenuated in vivo; however, previouslyMicrobe 12, 799–805, December 13, 2012 ª2012 Elsevier Inc. 801
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Figure 3. YopM Is a Pseudosubstrate Inhibitor of Caspase-1 Activity
(A) Macrophages were challenged or treated with YersiniaD, Salmonella
typhimurium, nigericin, or anthrax LT (10); retroviral transduction of YopM
blocks caspase-1 activation in response to each of these stimuli. Data are
presented as mean ± SEM.
(B) The conserved substrate recognition site bound by caspase-1 for selected
known substrates and inhibitors, aligned to the similar sequence identified in
YopM. The highly conserved aspartic acid is highlighted in red.
(C) Model of YopM (blue; PDB accession number 1G9U) docking Caspase-1
(yellow; PDB accession number 1BMQ) via pseudosubstrate site (red).
(D) Lysates frommacrophages undergoing pyroptosis (infectedwithYersiniaD,
lacking YopM) were incubated with 6xHis-YopM or 6xHis-YopM271A as bait for
pull-down and immunoblot detection of caspase-1. The sample loaded (L)
contains both the 45 kDa procaspase-1, as well as the cleaved p10 subunit
indicative of mature caspase-1. Caspase-1 was detected in the wash volumes
(W) with YopM271A but not YopM; the bound fraction (B) contained caspase-1
only when YopMwas used as bait. Enrichment of p10 over procaspase-1 in the
YopM-bound (B) fraction compared with the loading (L) indicates that YopM
may have a higher affinity for mature caspase-1.
(E) YopM, but not YopM271A, blocks proteolysis of caspase-1 substrate
YVAD-pNA.
See also Figure S2.
Cell Host & Microbe
Inflammasome Inhibition by Yersiniaidentified proteins that can bind YopM, a-thrombin, a1-antitryp-
sin, Rsk1, and Prk2 do not account this phenotype (Leung et al.,
1990; McDonald et al., 2003; McPhee et al., 2010). Thus, YopM
appears to have multiple targets and functions in vivo, like many
other toxins and effectors, and these activities may be intercon-
nected. The caspase-1 binding site of YopM is in a distinct
central region of the protein not required for Rsk1 binding
(McCoy et al., 2010; McPhee et al., 2010) or nuclear transloca-802 Cell Host & Microbe 12, 799–805, December 13, 2012 ª2012 Elstion (Trosky et al., 2008), but previously shown to be important
for virulence (Skrzypek et al., 2003). Mutation of the Rsk1 binding
site of YopM also disrupts a nuclear localization signal and may
contribute to caspase-1 inhibition, as both caspase-1 and viral
inhibitors of caspase-1 also translocate to the nucleus (Fank-
hauser et al., 2000; Rodriguez et al., 2003). Our observations
that YopM targets caspase-1 provide a mechanism for the
anti-inflammatory properties of YopM.
Disruption of inflammasome formation and caspase-1 activa-
tion is a successful strategy of Poxviruses, which use multiple
inhibitors that either block caspase-1 proteolysis or inhibit in-
flammasome formation (Lamkanfi and Dixit, 2009). Remarkably,
Yersinia has both activities in a single dual function virulence
factor. The bacterial origin of YopM possibly explains the lack
of structural homology to viral inhibitors, which appear to
be coopted host regulators (Li et al., 2008; Nathaniel et al.,
2004). Based on structural similarity, YopM is a potent, but
only partial, molecular mimic of Flightless-1, an endogenous
pseudosubstrate inhibitor containing a gelsolin-like domain
and leucine-rich repeats (Li et al., 2008). Furthermore, like
YopM, Flightless-1 inhibits both the activation and activity of
caspase-1. However, YopM also inhibits inflammasome forma-
tion, like CARD-containing inhibitors of caspase-1 activation.
Together, these observations suggest that Yersinia acquired
caspase-1 inhibitory activity through convergent evolution,
accounting for its unique, multipronged mechanism for inhibiting
caspase-1 and regulating inflammation.
These data highlight the importance of caspase-1 in
combating microbial infection and indicate that Yersinia are
highly susceptible to pyroptosis, but normally prevent cas-
pase-1 activation with YopM.Multiple Yersinia factors contribute
to minimizing inflammation by restricting availability of PAMPs;
direct targeting of caspase-1 and inflammasome formation
with YopM ensures that Yersinia can limit host inflammatory
responses and thereby establish infection.
EXPERIMENTAL PROCEDURES
Bacteria and Plasmids
Bacterial strains and plasmids are described in Table S1.
Cell Culture
Macrophages were generated from femur exudates of C57BL/6 (Jackson
Laboratories) or Caspase1/11/ (from C. Roy, Yale University) mice as
described in the Supplemental Experimental Procedures, activated with
100 ng/ml LPS (List Biologicals) 18 hr before infection.
Retroviral vectors (Table S1) were transfected into Ecotropic Phoenix cells
(ATCC). The recombinant viruses were transduced into macrophages, and
transductants were selected with puromycin.
Infection Conditions
Yersinia grown overnight at 25C were diluted 1:40 into LB with 20 mM MgCl2
and 20 mM Na2C2O4 and grown at 25
C for 1 hr then 37C for 2 hr. Bacteria
with expression plasmids were grown in media containing 50 mg/ml carbenicil-
lin and 0.02% arabinose. Bacteria washed in cold PBS were added to a multi-
plicity of infection (MOI) of 10 and spun onto macrophages at 150 g for 3 min.
NLRP1 was induced with 1 mg/ml anthrax lethal toxin subunits PA and LF (List
Biologicals), NLRP3 with 20 mM nigericin (Sigma-Aldrich), and NLRC4 with
Salmonella grown in LB overnight at 37C, diluted 1:40, and grown 3 hr in
LB containing 0.3 M NaCl. All infections and toxin treatments of macrophages
were for 1.5 hr unless otherwise stated. In Figure 3A, macrophages from
LT-susceptible BALB/c mice (Jackson Laboratories) were used. LDH releaseevier Inc.
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Figure 4. YopM Inhibits Inflammasome Formation and Caspase-1 Activation
Wild-type or casp1/ macrophages infected with Ypstb were fixed and protein localization visualized (A, C, E, G, and I) and quantified (B, D, F, and H) by
immunofluorescence microscopy. Both NLRP3 (A and B) and the inflammasome adaptor protein ASC (C and D) rapidly form foci (arrowheads) in response to
infection by Ypstbwhether expressing YopM (+pYopM), inactive YopM (+pYopM271A), or no YopM at all (YersiniaD) (blue, red, and green lines, respectively, in B,
D, F, and H). In contrast, recruitment of caspase-1 to foci is blocked by YopM but not YopM271A (E and F). Caspase-1 is not activated in cells in which YopM can
bind caspase-1 (G and H). In YopM-transduced, infected macrophages, YopM and caspase-1 colocalize (I). Representative confocal images are shown with
macrophage nuclei visible by DNA staining (blue) and foci indicated with arrowheads. Scale bars represent 10 mm. Data in (B), (D), (F), and (H) are presented as
mean ± SEM. See also Figure S3.
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Inflammasome Inhibition by Yersiniawas determined by Cytotox 96 kit (Promega) 2 hr after infection. In all other
experiments, infections were done in the presence of 5 mM glycine to protect
against cell lysis (Fink and Cookson, 2006).
Immunofluorescence Microscopy
Caspase-1 activation was determined by Fam-YVAD-FMK (Immunochemistry
Technologies) staining of macrophages infected on glass coverslips. After
PBS washing, cells were fixed with Cytofix (BD). Lysosomal exocytosis was
visualized by incubation of macrophages with anti-LAMP1 antibody (553792,
BD) before fixation, as previously (Bergsbaken et al., 2011). Immunofluores-
cent staining of other proteins was performed after fixation in Cytoperm (BD)
with antibodies specific to HA (32-6700, Invitrogen), NLRP3 (sc-66846, Santa
Cruz), ASC (AL177, Enzo), or Caspase-1 (sc-514, Santa Cruz) with Alexa fluor
secondary antibodies (Invitrogen). Coverslips mounted with ProLong (Molec-
ular Probes) were examined by confocal microscope (Leica SL or Zeiss LSM
510) at the W.M. Keck Center for Advanced Studies in Neural Signaling.
Caspase-1 activation or foci formation was enumerated by counting of the
fraction of positive cells in at least four separate fields.
Immunoblotting and Cytokine Analysis
Supernatants from infected macrophages were sterilized by 0.22 mm filter,
and IL-1b release was quantified by ELISA (R&D Systems) or concentrated
with a 10,000 MWCO Centricon Plus-20 centrifugal filter device (Millipore),
separated by SDS-PAGE, transferred to PVDFmembrane, and immunoblotted
with anti-IL-1b antibody (AF-401-NA, R&D Systems). Caspase-1 and YopMCell Host &immunoblots were performed with antibody against HA (sc-805 or 32-6700,
Invitrogen), 6xHis (37-2900, Invitrogen), or caspase-1 p10 (sc-514, Santa
Cruz), from cells lysed in M-PER protein extraction reagent (Thermo) with
sonication.
Protein Interaction and Functional Studies
Pyroptosis was induced in 107 macrophages by infection with YersiniaD
at MOI 10 for 2 hr. Lysates were added to 10 mg recombinant 6xHisYopM or
6xHisYopM271A bound to HisPur Cobalt Resin (Thermo Fisher) and incubated
at 4C for 2 hr. After four washes with binding buffer, bound proteins were
eluted with SDS-PAGE sample buffer containing imidazole and analyzed by
immunoblot.
Recombinant caspase-1 (10 U; Enzo) was preincubated with 6xHisYopM or
6xHisYopM271A for 5 min at 37
C in assay buffer (Enzo). Caspase-1 substrate
Ac-YVAD-pNA (Enzo) was added to 200 mM, and cleavage was detected by
monitoring of absorbance at 405 nm (Spectramax M3, Molecular Devices).
The suitability of the YLTD motif of YopM as a caspase-1 pseudosubstrate
was confirmed with the software PeptideCutter (ExPASy). Model interaction
between YopM and caspase-1 was created in PyMOL by superimposition of
the YLTD sequence of YopM (1G9U) with the YVAD bound to caspase-1
(1ICE).
Animal Experiments
Yersinia overnight cultures enumerated by Coulter counter (Multisizer 4,
Beckman Coulter) were diluted in PBS for intraperitoneal delivery of 1,000Microbe 12, 799–805, December 13, 2012 ª2012 Elsevier Inc. 803
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Inflammasome Inhibition by Yersiniacolony-forming units (CFU) in 100 ml to 6- to 8-week-old female mice. Mice
were monitored for survival (five mice each group) or sacrificed on day 4,
and tissue was homogenized and plated for CFU. Mice were housed in
specific pathogen-free conditions, and experiments performed in accordance
with University of Washington Institutional Animal Care and Use Committee
guidelines.
Statistical Analysis
Statistical significance was calculated by unpaired Student t test (*p < 0.05,
**p < 0.005) with GraphPad Prism, unless otherwise indicated. Data are repre-
sentative of at least three independent experiments.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.chom.2012.10.020.
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